EGRX - Eagle Pharmaceuticals Q1 2023 Earnings Preview
2023-05-08 13:09:44 ET
- Eagle Pharmaceuticals ( NASDAQ: EGRX ) is scheduled to announce Q1 earnings results on Tuesday, May 9th, before market open.
- The consensus EPS Estimate is $0.99 (-71.0% Y/Y) and the consensus Revenue Estimate is $63.33M (-45.4% Y/Y).
- Over the last 2 years, EGRX has beaten EPS estimates 38% of the time and has beaten revenue estimates 25% of the time.
For further details see:
Eagle Pharmaceuticals Q1 2023 Earnings Preview